Camlin Fine Sciences Ltd Nine Monthly Results

Gross Sales

1,252.32

1,211.37

1,254.86

1,022.86

860.48

Excise Duty

0

0

0

0

0

Net Sales

1,252.32

1,211.37

1,254.86

1,022.86

860.48

Other Operating Income

0

0

0

0

0

Other Income

15.3

9.79

9.98

11.72

2.89

Total Income

1,267.62

1,221.16

1,264.84

1,034.58

863.37

Total Expenditure

1,294.53

1,124.2

1,099.59

894.55

728.98

PBIDT

-26.91

96.96

165.25

140.03

134.39

Interest

83.92

44.14

48.72

26.01

25.43

PBDT

-110.83

52.82

116.53

114.02

108.96

Depreciation

55.28

58.56

44.58

40.02

32.47

Minority Interest Before NP

0

0

0

0

0

Tax

28.14

18.36

24.42

23.91

18.53

Deferred Tax

-36.02

-1.01

11.2

3.04

8.32

Reported Profit After Tax

-158.23

-23.09

36.33

47.05

49.64

Minority Interest After NP

-19.91

-7.48

-6.61

1.5

12.94

Net Profit after Minority Interest

-138.32

-15.61

42.95

45.55

36.7

Extra-ordinary Items

-125.46

0

0

0

0

Adjusted Profit After Extra-ordinary item

-12.86

-15.61

42.95

45.55

36.7

EPS (Unit Curr.)

-8.12

-0.94

2.73

3.57

3

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

16.75

16.75

15.71

12.76

12.75

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

-2.14

8

13.16

13.69

15.61

PBDTM(%)

-8.84

4.36

9.28

11.14

12.66

PATM(%)

-12.63

-1.9

2.89

4.59

5.76